Lacosamide as the first add-on therapy in adult patients with focal epilepsy: A multicenter real-world study
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2023.1136814
Abstract: Background Prospective observations on the effectiveness, safety, tolerance, and influence of comorbidity of add-on lacosamide (LCM) therapy are still lacking, especially for domestic generic LCM in China. Objective In this multicenter real-world study, we aimed… read more here.
Keywords: add therapy; therapy adult; first add; therapy ... See more keywords